acc4601 |
EGFR |
S-glutathionylation |
Cys797 |
human |
Lung Cancer |
A549 |
Cetuximab |
Positive |
5.0 |
30890751
|
acc4602 |
EGFR |
S-glutathionylation |
Cys797 |
human |
Lung Cancer |
A549 |
Erlotinib |
Positive |
5.0 |
30890751
|
acc4603 |
ERK1 |
phosphorylation |
Thr202 |
mouse |
Retinoblastoma |
MA-10 |
FGF9 |
Unresolved |
3.0 |
30191630
|
acc4604 |
ERK1 |
phosphorylation |
Tyr204 |
mouse |
Retinoblastoma |
MA-10 |
FGF9 |
Unresolved |
3.0 |
30191630
|
acc4605 |
ERK2 |
phosphorylation |
Thr185 |
mouse |
Retinoblastoma |
MA-10 |
FGF9 |
Unresolved |
3.0 |
30191630
|
acc4606 |
ERK2 |
phosphorylation |
Tyr187 |
mouse |
Retinoblastoma |
MA-10 |
FGF9 |
Unresolved |
3.0 |
30191630
|
acc4607 |
Rb |
phosphorylation |
Ser807 |
mouse |
Retinoblastoma |
MA-10 |
FGF9 |
Unresolved |
3.0 |
30191630
|
acc4608 |
Rb |
phosphorylation |
Ser811 |
mouse |
Retinoblastoma |
MA-10 |
FGF9 |
Unresolved |
3.0 |
30191630
|
acc4609 |
DR5 |
ubiquitination |
unclear |
human |
Renal Cancer |
Caki-1 |
TRAIL |
Negative |
5.0 |
32825566
|
acc4610 |
DR5 |
ubiquitination |
unclear |
human |
Renal Cancer |
ACHN |
TRAIL |
Negative |
5.0 |
32825566
|
acc4611 |
DR5 |
ubiquitination |
unclear |
human |
Renal Cancer |
A498 |
TRAIL |
Negative |
5.0 |
32825566
|
acc4612 |
DR5 |
ubiquitination |
unclear |
human |
Lung Cancer |
A549 |
TRAIL |
Negative |
5.0 |
32825566
|
acc4613 |
DR5 |
ubiquitination |
unclear |
human |
Breast Cancer |
MCF7 |
TRAIL |
Negative |
5.0 |
32825566
|
acc4614 |
Survivin |
ubiquitination |
unclear |
human |
Renal Cancer |
Caki-1 |
TRAIL |
Positive |
5.0 |
32825566
|
acc4615 |
Survivin |
ubiquitination |
unclear |
human |
Renal Cancer |
ACHN |
TRAIL |
Positive |
5.0 |
32825566
|
acc4616 |
Survivin |
ubiquitination |
unclear |
human |
Renal Cancer |
A498 |
TRAIL |
Positive |
5.0 |
32825566
|
acc4617 |
Survivin |
ubiquitination |
unclear |
human |
Lung Cancer |
A549 |
TRAIL |
Positive |
5.0 |
32825566
|
acc4618 |
Survivin |
ubiquitination |
unclear |
human |
Breast Cancer |
MCF7 |
TRAIL |
Positive |
5.0 |
32825566
|
acc4619 |
STAT3 |
phosphorylation |
Tyr705 |
mouse |
Nonseptic Shock |
|
Tyrphostin AG-490 |
Unresolved |
4.0 |
18656556
|
acc4620 |
STAT1 |
phosphorylation |
Tyr701 |
mouse |
Nonseptic Shock |
|
Tyrphostin AG-490 |
Unresolved |
4.0 |
18656556
|
acc4621 |
DDR1 |
phosphorylation |
Tyr |
mouse |
Renal Fibrosis |
|
compound2.45 |
Unresolved |
4.0 |
30452219
|
acc4622 |
Src |
phosphorylation |
Tyr416 |
human |
Renal Fibrosis |
HK-2 |
GW4064 |
Unresolved |
4.0 |
31298930
|
acc4623 |
YAP |
phosphorylation |
Ser127 |
human |
Renal Fibrosis |
HK-2 |
GW4064 |
Unresolved |
4.0 |
31298930
|
acc4624 |
Lats1 |
phosphorylation |
Ser909 |
human |
Renal Fibrosis |
HK-2 |
GW4064 |
Unresolved |
4.0 |
31298930
|
acc4625 |
Src |
phosphorylation |
Tyr416 |
human |
Renal Fibrosis |
HK-2 |
PP2 |
Unresolved |
4.0 |
31298930
|
acc4626 |
EGFR |
phosphorylation |
Tyr845 |
human |
Renal Fibrosis |
HK-2 |
PP2 |
Unresolved |
4.0 |
31298930
|
acc4627 |
p38 MAPK |
phosphorylation |
Thr180 |
mouse |
Renal Fibrosis |
|
Telmisartan |
Unresolved |
4.0 |
21381899
|
acc4628 |
p38 MAPK |
phosphorylation |
Tyr182 |
mouse |
Renal Fibrosis |
|
Telmisartan |
Unresolved |
4.0 |
21381899
|
acc4629 |
MAPKAPK-2 |
phosphorylation |
unclear |
mouse |
Renal Fibrosis |
|
Telmisartan |
Unresolved |
4.0 |
21381899
|
acc4630 |
Akt |
phosphorylation |
unclear |
mouse |
Renal Fibrosis |
|
Telmisartan |
Unresolved |
4.0 |
21381899
|
acc4631 |
Smad3 |
phosphorylation |
Ser423 |
mouse |
Renal Fibrosis |
|
BT173 |
Unresolved |
4.0 |
28220029
|
acc4632 |
Smad3 |
phosphorylation |
Ser425 |
mouse |
Renal Fibrosis |
|
BT173 |
Unresolved |
4.0 |
28220029
|
acc4633 |
AMPK |
phosphorylation |
Thr183 |
mouse |
Renal Injury |
|
14(15)-EET |
Unresolved |
4.0 |
30804206
|
acc4634 |
AMPK |
phosphorylation |
Thr172 |
mouse |
Renal Injury |
|
14(15)-EET |
Unresolved |
4.0 |
30804206
|
acc4635 |
AMPK |
phosphorylation |
Thr183 |
mouse |
Renal Injury |
|
1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl)urea |
Unresolved |
4.0 |
30804206
|
acc4636 |
AMPK |
phosphorylation |
Thr172 |
mouse |
Renal Injury |
|
1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl)urea |
Unresolved |
4.0 |
30804206
|
acc4637 |
Pax2 |
phosphorylation |
Ser393 |
mouse |
Renal Injury |
|
14(15)-EET |
Unresolved |
4.0 |
30804206
|
acc4638 |
Pax2 |
phosphorylation |
Ser393 |
mouse |
Renal Injury |
|
1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl)urea |
Unresolved |
4.0 |
30804206
|
acc4639 |
STAT3 |
phosphorylation |
Tyr705 |
mouse |
Renal Fibrosis |
|
Resveratrol |
Unresolved |
4.0 |
24976155
|
acc4640 |
STAT3 |
acetylation |
Lys685 |
mouse |
Renal Fibrosis |
|
Resveratrol |
Unresolved |
4.0 |
24976155
|
acc4641 |
STAT3 |
phosphorylation |
Tyr705 |
rat |
Renal Fibrosis |
NRK-52E |
Resveratrol |
Unresolved |
4.0 |
24976155
|
acc4642 |
STAT3 |
acetylation |
Lys685 |
rat |
Renal Fibrosis |
NRK-52E |
Resveratrol |
Unresolved |
4.0 |
24976155
|
acc4643 |
Smad2 |
phosphorylation |
unclear |
rat |
Cardiorenal Syndrome |
|
G226 |
Unresolved |
4.0 |
32305147
|
acc4644 |
NF-kappaB p65 |
phosphorylation |
Ser536 |
rat |
Renal Injury |
|
Benazepril |
Unresolved |
4.0 |
19018797
|
acc4645 |
VEGFR2 |
phosphorylation |
Tyr1175 |
human |
Neovascular Eye Disease |
HUVECs |
Curcumolide |
Unresolved |
4.0 |
31450226
|
acc4646 |
Src |
phosphorylation |
Tyr416 |
human |
Neovascular Eye Disease |
HUVECs |
Curcumolide |
Unresolved |
4.0 |
31450226
|
acc4647 |
FAK |
phosphorylation |
Tyr576 |
human |
Neovascular Eye Disease |
HUVECs |
Curcumolide |
Unresolved |
4.0 |
31450226
|
acc4648 |
FAK |
phosphorylation |
Tyr577 |
human |
Neovascular Eye Disease |
HUVECs |
Curcumolide |
Unresolved |
4.0 |
31450226
|
acc4649 |
ERK1 |
phosphorylation |
Thr202 |
human |
Neovascular Eye Disease |
HUVECs |
Curcumolide |
Unresolved |
4.0 |
31450226
|
acc4650 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Neovascular Eye Disease |
HUVECs |
Curcumolide |
Unresolved |
4.0 |
31450226
|